To demonstrate the value of an artificial intelligence (AI) software in the detection of mammographically occult breast cancers and to determine the clinicopathologic patterns of the cancers additionally detected using the AI software.
By retrospectively reviewing our institutional database (January 2017–September 2019), we identified women with mammographically occult breast cancers and analyzed their mammography with an AI software that provided a malignancy score (range 0–100; > 10 considered as positive). The hot spots in the AI report were compared with the US and MRI findings to determine if the cancers were correctly marked by the AI software. The clinicopathologic characteristics of the AI-detected cancers were analyzed and compared with those of undetected cancers.
Among the 1890 breast cancers, 6.8% (128/1890) were mammographically occult, among which 38.3% (49/128) had positive results in the AI analysis. Of them, 81.6% (40/49) were correctly marked by the AI software and determined as “AI-detected cancers.” As such, 31.3% (40/128) of mammographically occult breast cancers could be identified by the AI software. Of the AI-detected cancers, 97.5% were found in heterogeneously or extremely dense breasts, 52.5% were asymptomatic, 86.5% were invasive, and 29.7% had axillary lymph node metastasis. Compared with undetected cancers, the AI-detected cancers were more likely to be found in younger patients (p < 0.001), undergo neoadjuvant chemotherapy as well as mastectomy rather than breast-conserving operation (both p < 0.001), and accompany axillary lymph node metastasis (p = 0.003).
AI conferred an added value in the detection of mammographically occult breast cancers.
Hee Jeong Kim 1, Hak Hee Kim 2, Ki Hwan Kim 3, Woo Jung Choi 1, Eun Young Chae 1, Hee Jung Shin 1, Joo Hee Cha 1, Woo Hyun Shim 1
1Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.
2Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea. firstname.lastname@example.org.
3Lunit Inc., 15F, 27, Teheran-ro 2-gil, Gangnam-gu, Seoul, 06241, South Korea.
Photometric Transformer Networks and Label Adjustment for Breast Density Prediction
External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms
A Robust and Effective Approach Towards Accurate Metastasis Detection and pN-stage Classification in Breast Cancer
A Unified Framework for Tumor Proliferation Score Prediction in Breast Histopathology
Changes in cancer detection and false-positive recall in mammography using artificial intelligence: a retrospective, multireader study
Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study
Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms
Applying Data-driven Imaging Biomarker in Mammography for Breast Cancer Screening: Preliminary Study
Application of artificial intelligence–based computer-assisted diagnosis on synthetic mammograms from breast tomosynthesis: comparison with digital mammograms
Reducing Domain Gap by Reducing Style Bias
유방촬영의 위양성 판정에 관한 전통적 진단보조프로그램과 인공지능 기반 진단보조프로그램의 비교
인공지능 기반 컴퓨터 보조진단을 이용한 선별 유방촬영술에서의 간격암에 대한 후향 분석
Mammographic Surveillance After Breast Conserving Therapy: Impact of Digital Breast Tomosynthesis and Artificial Intelligence-Based Computer-Aided Detection
Diagnostic Performance of Artificial Intelligence-Based Computer-Aided Diagnosis for Breast Microcalcification on Mammography
Can artificial intelligence replace ultrasound as a complementary tool to mammogram for the diagnosis of the breast cancer?
Retrospective Review of Missed Cancer Detection and Its Mammography Findings with Artificial-Intelligence-Based, Computer-Aided Diagnosis
Mammographic Density Assessment by Artificial Intelligence-Based Computer-Assisted Diagnosis: A Comparison with Automated Volumetric Assessment
Artificial Intelligence for Breast Cancer Screening in Mammography (AI-STREAM): A Prospective Multicenter Study Design in Korea Using AI-Based CADe/x
Need of pretreatment support of breast cancer patient caregivers compared to patients.